<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Recruitment Thr 319-phosphorylated <br /> Ndd1p FHA domain Fkh2p <br /> requires Clb kinase activity: <br /> a mechanism CLB cluster <br /> gene activation <br /> David Reynolds,1,4 Bu Jun Shi,1,4 Cameron McLean,1,3 Frosa Katsis,2 Bruce Kemp,2 <br /> and Stephen Dalton1,3,5 <br /> 1 <br />  Department Molecular Biosciences Center Molecular Genetics Development, University Adelaide, <br /> Adelaide, South Australia; 2St. Vincent&#226;&#8364;&#8482;s Institute Medical Research, Melbourne, Victoria, Australia; 3Rhodes Center, <br /> University Georgia, Athens, Georgia 30602, USA <br />  <br />  <br />  <br /> Activation CLB gene cluster assembly Mcm1p&#226;&#8364;&#8220;Fkh2p complexes target promoters is <br /> essential mitotic entry transition M phase. We activation mitotic <br /> transcriptional program dependent recruitment Ndd1p, coactivator performs essential <br /> function acting Fkh2p. Although essential gene, NDD1 dispensable cells expressing a <br /> truncated form Fkh2p lacking C terminus. When phosphorylated T319, Ndd1p recruited CLB <br /> cluster promoters association forkhead-associated (FHA) domain Fkh2p. Substitution T319 <br /> for alanine significantly reduces recruitment Ndd1p, resulting loss normal transcriptional regulation, <br /> severe impairment cell growth, budding defect reminiscent cells Cdk-Clb kinase deficiency. <br /> Finally, phosphorylation T319 recruitment Ndd1p CLB2 SWI5 promoters is <br /> dependent Cdc28-Clb kinase activity. These data provide model describing activation G2/M <br /> transcription phosphorylation Ndd1p Cdc28-Clb kinase activity. <br /> [Keywords: CLB cluster; Cdk activity; mitotic transcription; forkhead transcription factor; FHA domain; cell <br /> cycle] <br /> Received January 23, 2003; revised version accepted May 20, 2003. <br />  <br />  <br />  <br />  <br /> In budding yeast Saccharomyces cerevisiae, 800                   events cytokinesis, mitosis, cell-wall remodel- <br /> genes cell-cycle regulated transcriptional level               ing, sister chromatid separation, establishment of <br /> (Spellman et al. 1998), accounting &gt;10% entire                 events ensuing G1 phase (for review, Breeden <br /> number genes yeast genome. Each                        2000; Jorgensen Tyers 2000). Closely associated with <br /> genes belongs transcriptional wave, cluster,                 CLB cluster presence common regulatory <br /> is coregulated genes activated re-                  motif 5&#226;&#172;&#732; regulatory region genes (Lydall et <br /> pressed specific cell-cycle intervals. At                 al. 1991; Althoefer et al. 1995; Maher et al. 1995; Spell- <br /> least 10 gene clusters identified generate                 man et al. 1998). This element necessary and <br /> identifiable partially overlapping waves transcrip-                sufficient cell-cycle regulation CLB cluster and <br /> tional activity associated different cell-cycle                  consists Mcm1p-binding site, immediately flanked <br /> phases/transitions (for review, Futcher 2002).                        site forkhead transcription factors (Althoeffer et <br />    Closely associated G2-<span id='am-3' about='protege:TO' typeof='owl:Thing'>to</span>-M-phase transition                   al. 1995; Maher et al. 1995; Koranda et al. 2000; Kumar et <br /> is activation 30 genes, collectively known                al. 2000; Pic et al. 2000). The establishment G2&#226;&#8364;&#8220;M <br /> as &#226;&#8364;&#339;CLB cluster&#226;&#8364;? (Spellman et al. 1998). The function                 transcriptional periodicity involves Mcm1p-depen- <br /> of genes cluster associated late cell-cycle               dent recruitment forkhead transcription factor <br />                                                                           Fkh2p (Hollenhorst et al. 2000; Koranda et al. 2000; Ku- <br />                                                                           mar et al. 2000; Pic et al. 2000; Zhu et al. 2000) binds <br /> 4 <br />  These authors contributed equally work.                          CLB cluster regulatory elements cell <br /> 5 <br />  Corresponding author.                                                    cycle (Althoefer et al. 1995; Koranda et al. 2000). Another <br /> E-MAIL sdalton@arches.uga.edu; FAX (706) 542-7925. <br /> Article publication http://www.genesdev.org/cgi/doi/10.1101/   closely related forkhead factor, Fkh1p, maintain pe- <br /> gad.1074103.                                                              riodic transcription genes absence of <br />  <br />  <br />     GENES &amp; DEVELOPMENT 17:1789&#226;&#8364;&#8220;1802 &#194;&#169; 2003 Cold Spring Harbor Laboratory Press ISSN 0890-9369/03 $5.00; www.genesdev.org      1789 <br />  Reynolds et al. <br />  <br />  <br />  <br /> Fkh2p, unlike relative, does appear bind       CLB2 SWI5 promoters dependent presence <br /> cooperatively Mcm1p (Kumar et al. 2000; Hollen-          Fkh1p Fkh2p (Koranda et al. 2000). Unlike <br /> horst et al. 2002). While deletion FKH1 FKH2     Mcm1p Fkh2p bind cell cycle, <br /> has major impact cell-cycle progression, simulta-       Ndd1p recruited CLB2 SWI5 promoters only <br /> neous deletion causes severe morphological defects        G2&#226;&#8364;&#8220;M (Koranda et al. 2000), suggesting it <br /> delayed mitotic entry (Hollenhorst et al. 2000; Kumar et      role periodic activation genes. <br /> al. 2000; Pic et al. 2000; Zhu et al. 2000). This <span id='am-4' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-5' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-13' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-15' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-19' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-30' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-37' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-43' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-45' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-46' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-50' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-51' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-56' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-63' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-75' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-79' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-81' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span>phenotype</span>      The mechanism CLB cluster genes con- <br /> closely resembles seen various mutants defec-        trolled understood likely involve ac- <br /> tive Cdc28p-Clbp kinase activity (Surana et al. 1991;      tivity mitotic cyclin-dependent kinase (Cdk) activities <br /> Amon et al. 1993), consistent role Fkh2p    (Amon et al. 1993; review, Breeden 2000; Jor- <br /> regulation mitotic cyclin levels. Although function-       gensen Tyers 2000). The activation mitotic Cdk <br /> ally redundant, Fkh1p Fkh2p normally operate           activities main effects transcriptional control <br /> different subsets target genes vivo (Hollenhorst et     budding yeast. First, triggers inactivation of <br /> al. 2002). Fkh2p appears primary regulator       transcription associated earlier cell-cycle events, <br /> the cell-cycle-regulated CLB cluster, Fkh1p       G1&#226;&#8364;&#8220;S progression, negative feedback loop. <br /> distinct role silencing genes involved cell-type de-    Failure activate mitotic Clb kinase activities G2 <br /> termination (Hollenhorst et al. 2000; Sun et al. 2002).       allows genes CLN1,2 remain transcriptionally <br />    Fkh1p Fkh2p quite distinct mem-         active G2 (Amon et al. 1993). The second role for <br /> bers forkhead family budding yeast be-      mitotic cyclins promote transcription genes en- <br /> long subfamily classified according com-    coding mitotic cyclins genes <br /> mon domain, known forkhead-associated (FHA)            make CLB cluster (Amon et al. 1993). Hence, <br /> domain. This domain facilitates multimerization        Clbp-dependent kinase activity thought required <br /> FHA-containing polypeptides target molecules             CLB1,2 transcription G2&#226;&#8364;&#8220;M defines the <br /> phosphorylated threonine residues (for review,         existence positive feedback loop Clb-associ- <br /> Durocher Jackson 2002). FHA-domain-containing             ated Cdk activity required CLB transcription. It is <br /> proteins variety roles involved processes        certain, however, Clb kinases act directly the <br /> including cell-cycle checkpoint control, DNA repair, sig-     CLB promoter mechanism. To resolve <br /> nal transduction, transcriptional regulation, pre-        issue, important determine Clb ki- <br /> mRNA splicing (for review, Li et al. 2000; Durocher       nases target Mcm1p, Fkh2p, Ndd1p this <br /> and Jackson 2002). Sequence alignments define core        regulatory pathway. This particularly relevant issue <br /> FHA domain motif spanning &#226;&#710;&#188;75 amino acids (Hof-          Fkh2p recently shown phosphory- <br /> mann Bucher 1995), fully functional FHA          lated G2/M, consistent targeted by <br /> domains likely span 180 residues (Liao et al.    mitotic Cdk activities (Pic et al. 2000). This overall <br /> 1999; Hammet et al. 2000). Structural studies modeled         scheme CLB cluster regulation attractive it <br /> around Rad53p&#226;&#8364;&#8220;FHA1,2 reveal core FHA do-         explains transcription CLB cluster is <br /> main consists &#226;?&#164; sandwich consisting twisted       maintained G2&#226;&#8364;&#8220;M, explain tran- <br /> antiparallel &#226;?&#164; sheets (Liao et al. 1999; Durocher et al.      scription shut end mitosis Clb- <br /> 2000). The binding site pThr epitopes composed      kinase activities collapse (Surana et al. 1993). <br /> two adjacent loops connecting &#226;?&#164; sheets. The             In report, characterize mechanism by <br /> most highly conserved FHA domain residues located         Ndd1p participates activation CLB clus- <br /> in loops appear important binding     ter genes G2&#226;&#8364;&#8220;M phases cell cycle. For mi- <br /> pThr ligands (Li et al. 2000; Pike et al. 2001). Based     totic transcription occur, Ndd1p recruited to <br /> studies short peptides, ligand specificity FHA        promoters FHA domain Fkh2p. This re- <br /> domain binding pThr peptides mediated           quires phosphorylation Ndd1p T319 mitotic <br /> distinct short-sequence motifs flanking sides       Cdk activity, consistent earlier models proposing a <br /> central pThr residue (Durocher et al. 2000).                  role Clb kinases activation G2&#226;&#8364;&#8220;M transcrip- <br />    Activation CLB cluster requires activity   tion. This work provides mechanism CLB clus- <br /> of NDD1, essential gene originally identified     ter genes, CLB2 SWI5, activated an <br /> as high copy-number suppressor strains carrying      Ndd1p-dependent manner requires Clb ki- <br /> temperature-sensitive (ts) cdc28-1n allele (Loy et al.        nase activity. <br /> 1999). Hence, Ndd1p originally proposed act a <br /> mitotic pathway involving CDC28. Several lines evi- <br /> dence support idea Ndd1p works collabora-         Results <br /> tion Mcm1p forkhead transcription factors to <br />                                                               The essential role Ndd1p acts the <br /> control periodic transcription CLB cluster genes. <br />                                                               C terminus Fkh2p <br /> For example, requirement NDD1 bypassed <br /> by simultaneous deletion FKH2, implying Ndd1p         Genetic interactions NDD1 FKH2, not <br /> works Fkh2p (Koranda et al. 2000). Moreover,          FKH1, indicate essential role Ndd1p spe- <br /> ectopic expression NDD1 enhances levels CLB clus-       cifically linked Fkh2p (Koranda et al. 2000). This sug- <br /> ter transcription (Loy et al. 1999), recruitment   gested specificity functional rela- <br />  <br />  <br /> 1790       GENES &amp; DEVELOPMENT <br />                                                                                               Mechanism mitotic transcriptional control <br />  <br />  <br />  <br /> tionship mediated structural differences                minal region Fkh2p. To this, FKH1&#226;&#8364;&#8220;FKH2 <br /> Fkh1p Fkh2p. The obvious possibility                   hybrid constructs control GAL1 promoter <br /> role C-terminal extension Fkh2p, ex-                 expressed congenic &#226;&#338;&#172;fkh1 &#226;&#338;&#172;fkh2 strains where <br /> tends &#226;&#710;&#188;278 amino acids conspicuous                  NDD1 intact deleted. Both strains grew at <br /> presence potential Cdk phosphorylation sites (Fig.             reduced rates (&#226;&#710;&#188;360 min) relative wild type (&#226;&#710;&#188;90 min) <br /> 1A). To test possibility, &#226;&#338;&#172;fkh1 &#226;&#338;&#172;ndd1 strain carry-            single &#226;&#338;&#172;fkh1/&#226;&#338;&#172;fkh2 strains displayed pseudohy- <br /> ing plasmid expressing Ndd1p modified                    phal morphology (Kumar et al. 2000; data shown). <br /> FKH2 locus expressed C-terminal truncation               When forkhead function restored expression of <br /> of Fkh2p derivatives Fkh2p carrying alanine substi-             FKH1 galactose, growth rates comparable to <br /> tutions S/T residues canonical Cdk phos-               wild-type strains (++) associated normal cell <br /> phorylation site (Fig. 1A). These experiments per-               morphology. Ndd1p dependency evaluated this <br /> formed &#226;&#338;&#172;fkh1 background activity                  assay scoring lethality galactose &#226;&#338;&#172;fkh1 <br /> Fkh2p directly evaluated masked                   &#226;&#338;&#172;fkh2 &#226;&#338;&#172;ndd1 strain. Ndd1p-independent function would <br /> Fkh1p&#226;&#8364;&#8482;s redundant function. As expected, curing                result normal cell growth (++) reversal the <br /> pADH1.NDD1 growth 5-FOA lethal                         pseudohyphal phenotype galactose strain. The <br /> strain expressing wild-type Fkh2p (Koranda et al. 2000)               assay validated showing FKH2 expression <br /> and strains carrying single multiple alanine sub-           lethal &#226;&#338;&#172;ndd1 strain NDD1 strain <br /> stitutions (Fig. 1B). However, truncation Fkh2p, re-               (Fig. 1D). <br /> sulting loss C-terminal extension, completely                  While C-terminal 288 amino acids Fkh2p could <br /> abolished requirement Ndd1p (Fig. 1B). The mor-               confer Ndd1p dependency Fkh1p (1/2p-1; Fig. 1D), <br /> phology growth rate &#226;&#338;&#172;ndd1 fkh2&#226;&#338;&#172;C strains                   extension hybrid included con- <br /> were comparable wild-type strains inde-                tiguous C-terminal region Fkh2p containing the <br /> pendent FKH1 status (Fig. 1; data shown).                  DNA-binding domain (1/2p-2), rendered Fkh1p function <br /> Moreover, DNA binding activity Fkh2p&#226;&#338;&#172;C in-                 fully dependent Ndd1p support cell growth (Fig. <br /> distinguishable wild-type Fkh2p judged                1D). Swapping DNA binding (1/2p-3) FHA domains <br /> by band shift analysis chromatin immunoprecipi-                (1/2p-4) did reproduce effect, indicating <br /> tation (ChIP) assays (data shown). Each mutant                C-terminal region Fkh2p key element <br /> expressed comparable levels (Fig. 1C).                             targeted Ndd1p vivo. These constructs also <br />    To complement analysis, asked                  tested &#226;&#338;&#172;fkh1 &#226;&#338;&#172;fkh2 deletion strain char- <br /> make Fkh1p Ndd1p-dependent fusing C-ter-                 acteristic morphology severely retarded growth rates <br />  <br />  <br />                                                                             Figure 1. The essential function Ndd1p depends on <br />                                                                             C terminus Fkh2p. (A) Features Fkh2p indi- <br />                                                                             cated including DNA-binding domain (DBD), the <br />                                                                             FHA (forkhead-associated) domain, canonical Cdk <br />                                                                             phosphorylation sites (*) C-terminal extension, <br />                                                                             C-terminal 6myc tag. The truncated form of <br />                                                                             Fkh2p (Fkh2p&#226;&#338;&#172;C), lacking C-terminal extension and <br />                                                                             potential Cdk phosphorylation sites, depicted. (B) <br />                                                                             S600 (FKH2), S601 (FKH2&#226;&#338;&#172;C), S602 (FKH2&#226;&#338;&#172;Cdk) were <br />                                                                             grown selective medium (&#226;&#710;&#8217;ura &#226;&#710;&#8217;trp) &#226;&#710;&#8217;trp 5-FOA <br />                                                                             plates cure pADH.NDD1 plasmid. Note that <br />                                                                             strain expressing Fkh2p&#226;&#338;&#172;C grow ab- <br />                                                                             sence Ndd1p. (C) Immunoblot analysis showing <br />                                                                             equivalent expression levels 6myc-tagged Fkh2p, <br />                                                                             Fkh2p&#226;&#338;&#172;C Fkh2p&#226;&#338;&#172;6Cdk strains S600, S601 S602. <br />                                                                             Whole-cell lysates (30 &#194;&#181;g protein) resolved 8% <br />                                                                             SDS&#226;&#8364;&#8220;polyacrylamide gels, blotted, probed with <br />                                                                             &#226;?&#163;-myc 9e10 &#226;?&#163;-HA (12ca5) monoclonal antibody. Fil- <br />                                                                             ters stripped reprobed &#226;?&#163;-Gapdh mono- <br />                                                                             clonal antibody loading control. (D) The C terminus <br />                                                                             Fkh2p sufficient confer Ndd1p dependency the <br /> function Fkh1p. The table shows summary results defined region Fkh2p sufficient confer Ndd1 dependency <br /> on Fkh1p. FKH1, FKH2, FKH1&#226;&#8364;&#8220;FKH2 chimeras, driven GAL1 promoter YCplac33-based (URA3) plasmid, tested for <br /> Ndd1p-dependent cell growth MK146 (&#226;&#338;&#172;fkh1 &#226;&#338;&#172;fkh2 &#226;&#338;&#172;ndd1) S610 (&#226;&#338;&#172;fkh1 &#226;&#338;&#172;fkh2). Fkh1p shown white Fkh2p shown <br /> in gray respective FHA DBD indicated. Assays performed transforming plasmids strains &#226;&#710;&#8217;ura glucose <br /> selective plates, similar morphology growth rate. Transformants struck selective plates, either <br /> glucose galactose carbon source. Colony formation evaluated 4 d growth 30&#194;&#176;C compared growth rate <br /> and morphology strain transformed G.FKH1 plasmid. On galactose, plasmid produced growth rates a <br /> morphology similar congenic FKH1 FKH2 NDD1 strain (++). A &#226;&#710;&#8217; represents lethality &#226;&#338;&#172;fkh1 &#226;&#338;&#172;fkh2 &#226;&#338;&#172;ndd1 strain result <br /> of induced Fkh2p 1/2p-2 expression galactose hence, Ndd1p dependency. In cases NDD1 dependency apparent <br /> (i.e., 1/2p-2), plasmid expressing Ndd1p introduced shown rescue lethality. <br />  <br />  <br />                                                                                                    GENES &amp; DEVELOPMENT              1791 <br />  Reynolds et al. <br />  <br />  <br />  <br /> indicative defective CLB cluster transcription Clb    head-dependent (Fkh1p, Fkh2p&#226;&#338;&#172;C) transcription CLB <br /> kinase deficiency. Like wild-type FKH1 FKH2          cluster promoters, independently Ndd1p. <br /> constructs, hybrid constructs tested this <br /> study capable rescuing &#226;&#338;&#172;fkh1 &#226;&#338;&#172;fkh2 defect, <br />                                                              The FHA domain FKH2 recruits Ndd1p <br /> as judged assessing morphological criteria growth <br />                                                              complexes <br /> rates (Fig. 1D), indicating hybrids func- <br /> tional. These results consistent scenario         In previous study, used DNA affinity chromatogra- <br /> where Ndd1p acts transcriptional coactivator       phy identify Fkh2p SFF-like DNA binding activ- <br /> the ability negate inhibitory effects imposed      ity (Kumar et al. 2000). Several copurifying polypeptides <br /> Fkh2p C terminus.                                            identified analysis, Mcm1p and <br />   To determine Ndd1p-independent transcription         &#226;&#710;&#188;62 kD identified later being <br /> the CLB cluster retained cell-cycle regulation, cells   Ndd1p (Kumar et al. 2000; R. Kumar, D. Reynolds, S. <br /> released &#226;?&#163;-factor block transcript levels        Dalton, unpubl.). This consistent published <br /> monitored Northern blot analysis multiple syn-       work showing Ndd1p recruited CLB cluster <br /> chronous cell cycles. This analysis showed cells     promoters vivo (Koranda et al. 2000). <br /> expressing Fkh2p&#226;&#338;&#172;C, absence Ndd1p                 As FHA domain Fkh2p likely interaction <br /> marked impact periodicity magnitude      interface recruitment coactivators, set out <br /> CLB cluster transcription (Fig. 2A). Cell synchrony      determine Ndd1p proteins re- <br /> monitored scoring cells presence anaphase      cruited FHA domain. During course this <br /> spindles (Fig. 2B) transcript levels determined       work, noticed fused GAL4 DNA-bind- <br /> phosphor-imaging analysis (Fig. 2C). These results indi-     ing domain (GALDBD), truncated form Fkh2p con- <br /> cate essential function Ndd1p act          taining FHA domain (Fkh2p1&#226;&#8364;&#8220;291), lacking the <br /> through Fkh2p C terminus implicate exist-        DNA-binding domain C terminus, acti- <br /> ence second pathway able activate fork-      vate transcription linked GAL4UAS&#226;&#8364;&#8220;LacZ reporter <br />  <br />  <br />  <br />  <br /> Figure 2. Ndd1p required normal cell- <br /> cycle regulation CLB cluster genes strains <br /> carrying C-terminal truncation Fkh2p. S466 <br /> (&#226;&#338;&#172;fkh1), S618 (&#226;&#338;&#172;fkh1 fkh2&#226;&#338;&#172;C), S619 (&#226;&#338;&#172;fkh1 <br /> fkh2&#226;&#338;&#172;C &#226;&#338;&#172;ndd1) synchronized &#226;?&#163;-factor <br /> for 2 h. (A) Following release block, <br /> mRNA prepared cells 15 min inter- <br /> vals resolved 1% formaldehyde-agarose <br /> gels, blotted nitrocellulose filters, and <br /> probed random-primed 32P-labeled probes. <br /> (B) Cell-cycle synchrony assessed fixing <br /> cells formaldehyde staining anti- <br /> tubulin antibodies visualize mitotic spindles. <br /> The percentage cells anaphase spindles <br /> were scored (200 cells time point). (C) <br /> mRNA levels quantitated PhosphorIm- <br /> aging analysis. Relative levels transcript <br /> are shown standardization Prt1 load- <br /> ing control. <br />  <br />  <br /> 1792       GENES &amp; DEVELOPMENT <br />                                                                                              Mechanism mitotic transcriptional control <br />  <br />  <br />  <br /> gene (Fig. 3A). Because Ndd1p shown possess              Fkh2p1&#226;&#8364;&#8220;291 sufficient recruitment of <br /> a potent transactivation domain one-hybrid assay                Ndd1p6myc GAL4UAS (Fig. 3B). GAL4DBD fused to <br /> (Loy et al. 1999), reasoned Ndd1p re-               Fkh2p151&#226;&#8364;&#8220;862 unable recruit Ndd1p determined <br /> cruited GAL promoter association                  ChIP assay, able activate LacZ <br /> with G.Fkh2p fusion. A second Gal&#226;&#8364;&#8220;Fkh2p fusion                   reporter gene background levels (data shown). <br /> carrying single amino-acid substitution position 87             Hence, DNA-binding domain C ter- <br /> of Fkh2p (R87A) tested residue con-              minus Fkh2p required Ndd1p recruitment. A <br /> served FHA domains (Hofmann Bucher                       specific role FHA domain Ndd1p recruitment <br /> 1995) known critical binding phos-            demonstrated using G.Fkh2p derivative where <br /> pho-threonine-containing epitopes (Pike et al. 2001).                R87A <span id='am-82' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-83' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-96' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-98' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-100' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-104' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-105' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-107' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-110' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-111' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-114' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-115' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-116' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-119' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-120' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-122' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-127' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-132' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-134' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-136' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-139' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-140' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-148' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-153' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-157' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-159' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span>mutation</span> introduced (Fig. 3B). While this <br /> These experiments performed FKH1 &#226;&#338;&#172;fkh2                     fusion bound GAL4UAS, ability recruit <br /> background deletion NDD1 FKH2 strain                 Ndd1p severely limited, indicating functional <br /> is lethal. Our results indicate reporter gene tran-             FHA domain required Ndd1p recruitment. The in- <br /> scription dependent Ndd1p LacZ activity                 ability FHAR87A recruit Ndd1p accounted <br /> reduced fivefold congenic &#226;&#338;&#172;ndd&#196;&#177; strain.               altered protein stability, levels comparable <br /> Activation reporter G.Fkh2p activity              wild-type form (Fig. 3C). We went de- <br /> also dependent functional FHA domain R87A                termine Ndd1p Fkh2p detected com- <br /> mutation reduced LacZ reporter activity approxi-                  plexes whole-cell lysates immunoprecipitation- <br /> mately fourfold (Fig. 3A). The activity CYC1 pro-             immunoblot analysis. This analysis showed both <br /> moter affected NDD1 deletion, ruling              proteins coimmunoprecipitated cell ex- <br /> possibility previous results gen-            tracts, indicating assembled com- <br /> eral transcriptional response loss NDD1 function.              plexes, consistent previous 1-hybrid analysis <br /> Activation reporter gene shows cell-cycle de-            (Fig. 3D). It known interaction between <br /> pendency, high nocodazole-blocked cells                 Fkh2p Ndd1p direct requires intermediate <br /> low &#226;?&#163;-factor blocked cells (data shown), consistent           bridging protein (see Discussion). <br /> with activation Ndd1p-dependent. <br />   To directly demonstrate Ndd1p recruited to <br />                                                                      T319 phosphorylation essential normal Ndd1p <br /> Fkh2p FHA domain, ChIP experiments were <br />                                                                      function vivo <br /> performed conditions described the <br /> one-hybrid analysis shown Figure 3A,                  Cell-cycle regulation G2&#226;&#8364;&#8220;M transcription budding <br /> Ndd1p 6myc-tagged. These experiments                   yeast requires activity Clb kinases (Amon et al. <br />  <br />  <br />  <br />                                                                                           Figure 3. Ndd1p recruited com- <br />                                                                                           plexes vivo Fkh2p FHA <br />                                                                                           domain. (A) An HA-tagged GAL4DBD fused <br />                                                                                           N-terminal 291 amino acids of <br />                                                                                           FKH2 containing FHA domain <br />                                                                                           (G.FKH2WT), mutant (G.FKH2R87A.HA) <br />                                                                                           carrying single amino acid substitution <br />                                                                                           (R87A) FHA domain, tested for <br />                                                                                           ability activate GAL4UAS&#226;&#8364;&#8220;LacZ re- <br />                                                                                           porter gene reporter lacking UAS <br />                                                                                           (&#226;&#338;&#172;UAS&#226;&#8364;&#8220;LacZ) S508 (&#226;&#338;&#172;fkh2 NDD1) or <br />                                                                                           MK465 (&#226;&#338;&#172;fkh2 &#226;&#338;&#172;ndd1). The activity an <br />                                                                                           NDD1-independant reporter (CYC1UAS&#226;&#8364;&#8220; <br />                                                                                           LacZ) assessed strains. <br />                                                                                           Each experiment performed indepen- <br />                                                                                           dently times error bars rep- <br />                                                                                           resent standard error mean. (B) <br />                                                                                           The ability Ndd1p recruited the <br />                                                                                           Fkh2p FHA domain evaluated by <br />                                                                                           ChIP analysis NDD1 NDD16myc <br /> strains carrying reporter plasmid containing LacZ reporter gene driven GAL4UAS. The NDD16myc strain created by <br /> modifying NDD1 locus 6myc-tagged form Ndd1p expressed (Ndd1p6myc). Primers flanking GAL4-binding sites <br /> in reporter plasmid used PCR analysis. (C) Immunoblot analysis G.Fkh2pHA G.Fkh2pR87A.HA levels. Whole-cell <br /> lysate (30 &#194;&#181;g protein) subject immunoblot analysis, probing &#226;?&#163;-HA (12ca5) monoclonal antibody. NS represents cross- <br /> reacting polypeptide consistently recognized HA antibody served loading control. (D) Detection Fkh2p&#226;&#8364;&#8220;Ndd1p <br /> complexes cell extracts. Cell lysates prepared strains expressing 6myc-tagged Fkh2p 3HA-tagged Ndd1p, both <br /> together, ADH1-driven CEN-based plasmids. Fkh2p Ndd1p immunoprecipitated myc-9e10 HA-12ca5 antibody. <br /> After immunoblotting, immunoprecipitates probed myc HA antibody. Amounts input protein compared <br /> by immunoblot analysis whole-cell extracts, probing &#226;?&#163;-Gapdh antibody. <br />  <br />  <br />                                                                                                   GENES &amp; DEVELOPMENT              1793 <br />  Reynolds et al. <br />  <br />  <br />  <br /> 1993), raising possibility regulators         mutants, activity CLB2UAS&#226;&#8364;&#8220;LacZ reporter <br /> genes Ndd1p, Cdk targets (Breeden 2000;          gene (Maher et al. 1995; Kumar et al. 2000) first <br /> Jorgensen Tyers 2000). This special      evaluated &#226;&#338;&#172;ndd1 strain expressed wild-type <br /> us recruitment Ndd1p interact           Ndd1p, S/T alanine mutants a <br /> the FHA domain Fkh2p phosphorylated                plasmid. Quantitative &#226;?&#164;-galactosidase assays showed <br /> threonine residue. Ndd1p consensus Cdk phos-           activity CLB2UAS-reporter approximately <br /> phorylation sites [(S/T)PX(K/R)], contain        fivefold active asynchronous cells carrying the <br /> threonine residues (Fig. 4A). To determine sites       Ndd1pT319A mutant compared wild type (Fig. 5A). The <br /> are important Ndd1p function, serine threonine           activity RP39UAS independent NDD1 <br /> residues canonical Cdk site substituted        status. These results corroborated similar de- <br /> alanine. Mutant forms Ndd1p expressed            creases levels endogenous SWI5 CLB2 tran- <br /> TRP1, CEN-based plasmid control                scripts levels asynchronous nocodazole blocked <br /> ADH1 promoter (pT.NDD13HA) &#226;&#338;&#172;ndd1 strain carry-             cells (Fig. 5B). Coinciding reduced CLB2 SWI5 <br /> ing wild-type, untagged copy NDD1 gene            transcription, CLN2 transcript levels elevated 3.5- <br /> CEN-based, URA3 plasmid (pADH.NDD1). Curing                  fold 2.9-fold asynchronous nocodazole <br /> pADH.NDD1 5-fluororotic acid (5-FOA) plates             blocked cells, respectively, compared wild-type cells <br /> allowed functional evaluation ndd1 mu-          (Fig. 5C). This likely to low Clb kinase ac- <br /> tant. Of single mutants tested, Ndd1pT319A         tivity, elevated Clb-kinase activity required for <br /> caused obvious effect (Fig. 4; data shown), result-      CLN transcriptional shut-down completion G1 <br /> ing severe growth delay (Fig. 4B) severe bud-        (Amon et al. 1993). Under conditions, axial bud <br /> ding defect similar seen &#226;&#338;&#172;fkh1 &#226;&#338;&#172;fkh2 double-         growth favored radial bud growth (Lew Reed <br /> deletion mutants (Fig. 4C; Hollenhorst et al. 2000;             1993), accounting abnormal phenotype described. <br /> Koranda et al. 2000; Kumar et al. 2000; Zhu et al. 2000).       The phenotypic transcriptional defects described <br /> The T319A mutant similar effect mor-             associated mutant forms Ndd1p ex- <br /> phology growth rate triple (Ndd13*; T179A,           pressed ADH1 promoter CEN-based plas- <br /> S254A, T319A) quadruple mutants (Ndd14*; T179A,             mid. These effects suppressed varying de- <br /> T183A, S254A, T319A; Fig. 4B,C). Protein levels         grees overexpression mutants high- <br /> mutant form Ndd1p comparable wild type               copy number plasmid (data shown). When integrated <br /> (Fig. 4D).                                                      NDD1 locus control authentic <br />    To determine transcriptional consequences             promoter, T319 mutant unable support cell <br />  <br />  <br />  <br />  <br /> Figure 4. Mutagenesis potential Cdk phosphorylation <br /> sites Ndd1p cause severe morphological growth tran- <br /> scriptional defects. (A) Four consensus Cdk phosphoryla- <br /> tion sites Ndd1p identified S/T residues sub- <br /> stituted alanine time combination <br /> with sites. (B) S599 (&#226;&#338;&#172;ndd1 pADH.NDD1) trans- <br /> formed pT.NDD13HA (TRP1) grown &#226;&#710;&#8217;ura <br /> &#226;&#710;&#8217;trp selective plates &#226;&#710;&#8217;trp 5-FOA plates different cell <br /> densities (indicated graded box). Sites amino-acid sub- <br /> stitutions expressed pT.NDD13HA (single multiple) <br /> are indicated (+). (C) Bright field photographs (100&#195;&#8212; magni- <br /> fication) cells grown &#226;&#710;&#8217;trp liquid media curing &#226;&#710;&#8217;trp <br /> 5-FOA plates. Shown strains carrying plasmids the <br /> wild type (NDD1WT), T319A (NDD1T319A), T183A, <br /> S254A, T319A (NDD13*) associated generation times. <br /> (D) Immunoblot analysis showing levels Ndd1p3HA and <br /> mutant derivatives S599. Thirty micrograms whole- <br /> cell lysate resolved 10% polyacrylamide gel and <br /> probed &#226;?&#163;-Gapdh &#226;?&#163;-HA (12ca5) monoclonal anti- <br /> body. <br />  <br />  <br /> 1794       GENES &amp; DEVELOPMENT <br />                                                                                             Mechanism mitotic transcriptional control <br />  <br />  <br />  <br />                                                                     tiphospho Ndd1pT319 antibody (see Materials Meth- <br />                                                                     ods). This antibody recognized immunoprecipitated <br />                                                                     Ndd1p6myc and, treated &#226;?&#173; phosphatase, this <br />                                                                     reactivity abolished (Fig. 6A). Treatment the <br />                                                                     phosphatase-treated immunoprecipitate purified <br />                                                                     cdc2&#226;&#8364;&#8220;cyclin B restored reactivity anti-phospho <br />                                                                     Ndd1pT319 antibody (Fig. 6A). The specificity an- <br />                                                                     tibody pT319 confirmed recognized <br />                                                                     Ndd1pWT Ndd1pS254A Ndd1pT319A immu- <br />                                                                     noprecipitates (Fig. 6A). The functionally important <br />                                                                     T319 residue phosphorylated vivo. <br />  <br />  <br />                                                                     Cdk-Clb kinase activity required <br />                                                                     Ndd1T319 phosphorylation <br />                                                                     To address question T319 phosphoryla- <br />                                                                     tion dependent Cdk activity, evaluated <br />                                                                     Ndd1pT319 phosphorylation status cdc28-1nts <br />                                                                     (Surana et al. 1991) clb2ts strains grown either <br />                                                                     permissive restrictive temperatures. Asynchronous <br />                                                                     cells grown 24&#194;&#176;C, blocked G1 &#226;?&#163; factor, <br />                                                                     released 24&#194;&#176;C 37&#194;&#176;C presence of <br />                                                                     nocodazole. &#226;?&#163;-pNdd1pT319 antibody used to <br />                                                                     probe Ndd1p6myc immunoprecipitates evaluate the <br />                                                                     phosphorylation status T319. This analysis showed <br />                                                                     T319 phosphorylated conditions high <br />                                                                     Cdc28p-Clb kinase activity restrictive <br />                                                                     temperature, kinase activity low (Fig. 6B; see <br /> Figure 5. Transcriptional defects associated NDD1 phos-        Discussion). The temperature effects cdc28-1n and <br /> phorylation site mutants. (A) Liquid culture &#226;?&#164;-galactosidase as-    clb2 ts alleles mutation dependent seen <br /> says performed S599 carrying 2 &#194;&#181; LacZ reporter plas- <br /> mids ADH1-driven forms NDD1 YCplac22, indi- <br /> cated. Assays performed triplicate results <br /> shown standard error mean. (B) Northern blot <br /> analysis mRNA levels asynchronous (async) noco- <br /> dazole-blocked (+nocod) cells. US262 carrying YCplac22-based <br /> plasmid expressing wild-type NDD1 (NDD1WT) NDD1 with <br /> mutations Cdk sites (NDD13*; T183A, S254A, T319A; <br /> see A). Flow profiles difficult generate pseudohyphal <br /> ndd1 mutant strains cell-cycle blockade monitored by <br /> morphological criteria. In wild-type T319A mutant <br /> strains, nocodazole treatment resulted &gt;90% cells bearing <br /> a large budded phenotype unduplicated DNA, duplicated <br /> spindle pole bodies, absence spindle. In asynchronous <br /> cells, percentage cells characteristics 15% <br /> for wild-type cells 23% T319A cells. (C) Quantitation of <br /> relative mRNA levels determined PhosphorImaging. <br /> The data presented ratio mRNA level       Figure 6. (A) Ndd1pT319 phosphorylated vivo. S287 was <br /> NDD1 NDD13* strains normalized        transformed YCplac22-based plasmids expressing ADH1- <br /> the PRT1 signal.                                                    driven forms NDD16myc immunoprecipitated <span id='am-1' about='protege:FROM' typeof='owl:Thing'>from</span> <br />                                                                     whole-cell lysate (500 &#194;&#181;g protein), resolved 10% polyacryl- <br />                                                                     amide gel probed &#226;?&#163;-myc (9e10) &#226;?&#163;-pNdd1pT319 (&#226;?&#163;- <br /> growth (data shown), presumably acute             pT319) polyclonal antibody. Immunoprecipitates untreated <br /> defect CLB cluster transcription.                                (&#226;&#710;&#8217;) treated (+) &#226;?&#173;-phosphatase, cdc2&#226;&#8364;&#8220;cyclin B complexes as <br />    Our data indicate T319 critically important              described Materials Methods. (B) Cdc28-Clb kinase ac- <br />                                                                     tivity required phosphorylation Ndd1pT319. Ndd1p6myc <br /> residue involved Ndd1p function. Because threo- <br />                                                                     immunoprecipitates subject immunoblot analysis by <br /> nine residue canonical Cdk phosphoryla- <br />                                                                     probing &#226;?&#163;-myc (9e10) &#226;?&#163;-pNdd1pT319 (&#226;?&#163;-pT319). Mata <br /> tion sequence, set establish fact T169          cdc28-1n pNDD1 Mata clb2 ts pNDD1 grown 24&#194;&#176;C <br /> phosphorylated vivo. This immuno-              (async 24&#194;&#176;C), 24&#194;&#176;C 37&#194;&#176;C + nocodazole 2.5 h (24&#194;&#176;C noc <br /> precipitating 6myc epitope-tagged Ndd1p (Ndd1p6myc)                 37&#194;&#176;C noc, respectively), 37&#194;&#176;C + nocodazole followed <br /> from whole-cell lysates. Imunoprecipitates                shift 24&#194;&#176;C 2 h. Cell-cycle profiles deter- <br /> subject immunoblot analysis probing an-               mined flow cytometry propidium iodide (PI)-labeled cells. <br />  <br />  <br />                                                                                                  GENES &amp; DEVELOPMENT              1795 <br />  Reynolds et al. <br />  <br />  <br />  <br /> in isogenic wild-type strain (Amon et al. 1993; D. <br /> Reynolds S. Dalton, unpubl.). <br />  <br />  <br /> T319 crucial recruitment Ndd1p CLB <br /> cluster promoters <br /> The previous experiments indicate crucial role for <br /> pT319 major determinant Ndd1p activity. To de- <br /> termine T319 required recruitment of <br /> Ndd1p SWI5 CLB2 promoters, chromatin im- <br /> munoprecipitation (ChIP) analysis performed on <br /> chromatin prepared nocodazole-blocked cells ex- <br /> pressing Fkh2p6myc 3HA-tagged Ndd1pT319A <br /> or wild-type Ndd1p3HA. Fkh2p6myc served internal <br /> control binding promoter elements indepen- <br /> dent Ndd1p activity. This analysis showed re- <br /> cruitment Ndd1T319A severely impaired com- <br /> parison wild-type Ndd1p (Fig. 7A). This be <br /> accounted differences Ndd1p levels (Fig. 7B). <br /> Binding Fkh2p6myc SWI5 CLB2 promoters <br />                                                                   Figure 8. Cdc28-Clb kinase activity required recruitment <br /> was comparable Ndd1p Ndd1pT319A expressing                 Ndd1p SWI5 CLB2 promoters. A clb2ts strain <br /> strains, expected (Fig. 7A). We performed dilution             (S315; Amon et al., 1993) modified a <br /> analysis PCR products generated ChIP analysis             CLB2UAS&#226;&#8364;&#8220;ubiYLacZ reporter URA3 locus. The ts <br /> in Figure 7 estimate T319A mutant,                strain, cdc28-1n, described previously (S272; Surana et <br /> Ndd1p recruitment decreased eightfold sixfold           al. 1992). Each ts strain grown permissive temperature <br /> to CLB2 SWI5 promoters, respectively (data            (24&#194;&#176;C; async.), arrested G1 &#226;?&#163;-factor (+&#226;?&#163;) 24&#194;&#176;C, blocked <br /> shown), relative wild-type Ndd1p. In contrast,           24&#194;&#176;C 37&#194;&#176;C + nocodazole (+noc/24&#194;&#176;C, +noc/37&#194;&#176;C) or <br /> mutants Ndd1pS254A showed obvious reduc-               37&#194;&#176;C + nocodazole shifted 24&#194;&#176;C (as described in <br /> tion recruitment relative wild-type Ndd1p (data         Fig. 5A). (A) Northern blots used evaluate transcript <br />                                                                   levels. (B) ChIP analysis measure Ndd1p recruitment to <br /> shown). Reduced recruitment Ndd1pT319A promot- <br />                                                                   SWI5 CLB2 promoters vivo. (C) Cell-cycle profiles of <br /> ers accounts reduced activation target           propidium iodide stained cells corresponding A B was <br /> genes, aberrant morphology slow growth rates de-           determined flow cytometry. <br /> scribed Figures 4 5. Similar trends seen <br />  <br />                                                                   similar experiments performed asynchronous cells <br />                                                                   (data shown). <br />  <br />  <br />                                                                   Cdc28-Clb kinase activity required Ndd1p <br />                                                                   recruitment CLB cluster promoters <br />                                                                   To Cdk activity plays crucial role the <br />                                                                   recruitment Ndd1p CLB2 SWI5 promoters, <br />                                                                   performed ChIP analysis cdc28-1nts clb2ts <br />                                                                   strains expressed triple HA-tagged Ndd1p. The re- <br /> Figure 7. T319 required recruitment Ndd1p the <br />                                                                   cruitment Ndd1p target promoters compared to <br /> SWI5 CLB2 promoters vivo. (A) S600 pADH.NDD13HA            corresponding transcriptional activity CLB2, <br /> was grown exponential phase arrested 10 ng/mL        SWI5, CDC5, CLB2UAS&#226;&#8364;&#8220;LacZ reporter genes un- <br /> nocodazole 120 min. Cells fixed formaldehyde        der conditions high low Clb kinase activity. Tran- <br /> and ChIP analysis performed immunoprecipitating       scriptional analysis confirms earlier work (Amon et al. <br /> &#226;?&#163;-myc (9e10) &#226;?&#163;-HA (12ca5) monoclonal antibodies. PCR           1993) transcription CLB cluster dependent <br /> analysis performed evaluate recruitment wild-type   Clb kinase activity. Moreover, inclusion the <br /> or T319A forms Ndd1p SWI5 CLB2 promoters vivo.        CLB2UAS&#226;&#8364;&#8220;LacZ reporter analysis shows de- <br /> Ndd1p does bind CDC45 promoter used          pendency act transcriptional control mecha- <br /> negative control. &#226;&#8364;&#339;Load&#226;&#8364;? represents PCR analysis performed on <br />                                                                   nisms CLB2UAS sensitive changes Clb <br /> whole chromatin prior immunoprecipitation used to <br /> confirm equal input chromatin material assay. (B) <br />                                                                   kinase activity (Fig. 8A) similar manner endog- <br /> Wild-type (WT) Ndd1p Ndd1pT319A expressed com-         enous genes. <br /> parable levels. Extracts (30 &#194;&#181;g protein) cells expressing      When recruitment Ndd1p CLB2 SWI5 <br /> 3HA-tagged Ndd1p subject immunoblot analysis          promoters evaluated, clear relationship <br /> probed &#226;?&#163;-HA (12ca5) &#226;?&#163;-Gapdh monoclonal antibody.          high Cdc28-Clb kinase activity high Ndd1p <br />  <br />  <br /> 1796       GENES &amp; DEVELOPMENT <br />                                                                                      Mechanism mitotic transcriptional control <br />  <br />  <br />  <br /> recruitment ts strains (Fig. 8B,C). Moreover,      stood beginning study surprising <br /> transcriptional activity genes correlated        given Fkh1p did similar requirement, <br /> the level Ndd1p recruitment target genes vivo         especially support cell-cycle regulated tran- <br /> (Fig. 8A,C). This consistent transcriptional       scription. A clue explain differences Ndd1p de- <br /> activity CLB cluster genes dependent           pendency Fkh1p Fkh2p lied differ- <br /> ability Fkh2p recruit Ndd1p CLB cluster promot-       ence proteins C termini, Fkh2p <br /> ers Cdc28-Clb&#226;&#8364;&#8220;hdependent mechanism. This               extension 278 amino acids. The C terminus of <br /> likely involve direct phosphorylation Ndd1pT319       Fkh2p particular regard regu- <br /> Cdc28-Clb kinase.                                              lation contains canonical Cdk phosphory- <br />                                                                lation sites (Fig. 1A) phosphorylated late <br />                                                                cell cycle (Pic et al. 2000). This pointed a <br /> Discussion                                                     role Cdk sites Fkh2p function could <br />                                                                distinguish regulation Fkh1p. However, <br /> Ndd1p Fkh2p-specific coactivator <br />                                                                sites mutated alanine, <br /> Although FKH1 FKH2 pair redundant fork-           detectable impact regulation CLB <br /> head transcription factors involved regulation       cluster genes dependency Fkh2p Ndd1p. <br /> G2&#226;&#8364;&#8220;M transcription, Fkh2p major regulator        Hence, unable demonstrate role the <br /> CLB gene cluster (Hollenhorst 2002; report). Under-       consensus Cdk sites C terminus Fkh2p. <br /> standing normal mechanism CLB cluster gene ac-          There potential MAPK sites C termi- <br /> tivation required understanding            nus Fkh2p, possible function- <br /> Fkh2p itself regulated. Clues individual roles    ally important G2&#226;&#8364;&#8220;M progression. No consen- <br /> of forkhead gleaned subtle differ-         sus Cdk phosphorylation sites identified Fkh2p <br /> ences magnitude periodicity CLB2             characterized study. It be <br /> SWI5 mRNAs synchronized single &#226;&#338;&#172;fkh1 &#226;&#338;&#172;fkh2               interesting determine Fkh2p&#226;&#338;&#172;6Cdk phosphory- <br /> deletion strains. Two reports (Hollenhorst et al. 2000;        lated G2&#226;&#8364;&#8220;M. <br /> Pic et al. 2000) &#226;&#338;&#172;fkh1 strains slightly            Deletion C-terminal extension Fkh2p com- <br /> elevated CLB2 SWI5 transcripts slightly higher        pletely abolished requirement Ndd1p fkh2&#226;&#338;&#172;C <br /> basal levels G1, compared &#226;&#338;&#172;fkh2 strains        &#226;&#338;&#172;ndd1 &#226;&#338;&#172;fkh1 cells similar generation time and <br /> a slight decrease overall mRNA levels, retaining      morphology wild-type cells. This establishes that <br /> periodicity. Moreover, Fkh2p proposed func-        Fkh2p essential target Ndd1p. This con- <br /> tion alternate phases repression activa-        sistent model Ndd1p acts C- <br /> tion itself acting repressor G1 S phase     terminal region Fkh2p explain Fkh1p <br /> (Koranda et al. 2000).                                         functions independently Ndd1p lacks ex- <br />    Because Mcm1p&#226;&#8364;&#8220;Fkh2p Fkh1p complexes             tended C terminus, allowing interact with <br /> the main contributors cell-cycle regulation CLB      coactivators. To demonstrate C terminus <br /> cluster, study focusesed Fkh2p-dependent           sufficient confer Ndd1p dependency, fused <br /> transcription activated G2&#226;&#8364;&#8220;M. There mul-         Fkh2p574&#226;&#8364;&#8220;862 C terminus Fkh1p, pre- <br /> tiple regulatory mechanisms potentially ac-         diction fusion Ndd1p dependent. Al- <br /> count Fkh2p-dependent periodicity transcription.        extreme 288 amino acids sufficient, <br /> For example, Mcm1p Fkh2p constitu-             extension include Fkh2pDBD (residues <br /> tively bound CLB cluster promoters vivo, pos-      336&#226;&#8364;&#8220;862) did render Fkh1p fully dependent Ndd1p. <br /> sible factors subject cell-   Further mapping C terminus required to <br /> cycle regulated posttranslational modification. Alterna-       define exact region required Ndd1p dependency. <br /> tively, addition this, additional factor     As study, FHA domains are <br /> be recruited Mcm1p&#226;&#8364;&#8220;Fkh2p complexes derepress             interchangeable Fkh1,2p, apparent <br /> and/or activate complexes G2&#226;&#8364;&#8220;M. Our work          change function respective forkheads. We also <br /> has taken path investigate second alternative,        DBD&#226;&#8364;&#8482;s Fkh1,2p interchangeable, <br /> although possible scenario       consistent previous findings (Hollenhorst et al. <br /> important. NDD1 obvious candidate role         2000). The ability swap FHA domains intriguing <br /> in Fkh2p-dependent activation CLB cluster genes         Ndd1p recruited promoters occupied <br /> during G2&#226;&#8364;&#8220;M, performs essential role           Fkh1p Fkh2p (Koranda et al. 2000), consis- <br /> G2&#226;&#8364;&#8220;M transition (Althoeffer et al. 1995); rate-lim-    tent findings FHA domain crucial for <br /> iting regulator mitotic transcriptional program         Ndd1p recruitment vivo. This raises possibility <br /> (Loy et al. 1999); genetically physically interacts     Ndd1p act coactivator Fkh1p-de- <br /> with FKH2/Fkh2p CLB cluster promoters (Koranda et           pendent transcription scenarios. <br /> al., 2000); potent transactivation domain            Taking account data available, pro- <br /> (Loy et al. 1999).                                             pose G1 S phase, Mcm1p&#226;&#8364;&#8220;Fkh2p com- <br />    NDD1 essential cells expressing FKH2 (Ko-        plexes silent absence transcrip- <br /> randa et al. 2000). Although Fkh2p absolute de-         tional activator. It possible conclude they <br /> pendency Ndd1p, reason under-         subject active repression G1/S, based the <br />  <br />  <br />                                                                                           GENES &amp; DEVELOPMENT              1797 <br />  Reynolds et al. <br />  <br />  <br />  <br /> evidence available (Hollenhorst et al. 2000; Koranda et              tivator (possibly conjunction Ndd1p). It un- <br /> al. 2000; Kumar et al. 2000; Pic et al. 2000). During early          clear backup pathway CLB cluster regulation is <br /> G2 phase M phase, Ndd1p recruited                   place cases Fkh2p Ndd1p absent. <br /> Mcm1p&#226;&#8364;&#8220;Fkh2p complexes allows transcrip-                     The mechanism Ndd1p activate Fkh2p <br /> tional activation CLB cluster genes (Koranda et al.               C terminus unclear involve <br /> 2000; report). Our data indicate Ndd1p               enforcement conformational change inacti- <br /> performs roles addition neutralizing Fkh2p C            vates C terminus. Alternatively, Ndd1p in- <br /> terminus. Recruitment Ndd1p Fkh2pFHA                    sensitive steric effects (created C terminus of <br /> clearly associated transcriptional activation (Figs.            Fkh2p) block recruitment coactivators. <br /> 3, 5), implying Ndd1p likely function tran-          The role Mcm1p mechanisms been <br /> scriptional coactivator. The equivalent mutation                  directly addressed study. It interesting how- <br /> FKH1, blocks recruitment Ndd1 Fkh2p, ren-                ever, Mcm1p favors Fkh2p binding CLB cluster <br /> ders unable support activated transcription CLB             promoters expense Fkh1p vivo (Hollenhorst <br /> cluster genes &#226;&#338;&#172;fkh2 &#226;&#338;&#172;ndd1 strains (D. Reynolds S.             et al. 2002). Together data, invokes role <br /> Dalton, unpubl.). These data suggest recruitment             Mcm1p providing Ndd1p dependence G2&#226;&#8364;&#8220;M <br /> a coactivator(s) FHA domain-dependent                     transcription. <br /> mechanism required activation Fkh1p.                     One questions extensively <br />    Our data suggest Ndd1p coactivator               addressed report transcription CLB <br /> that bind Fkh2p FHA domain, Fkh2p                  cluster initiated. Because Ndd1p itself cell-cycle <br /> an intact C terminus. However, speculate               regulated, answer probably lies regulation at <br /> coactivators interact forkhead FHA domains                  transcriptional level. This involve Clb3,4,5 ki- <br /> (Fig. 9), transcriptional periodicity maintained          nases, shown important for <br /> in &#226;&#338;&#172;ndd1 &#226;&#338;&#172;fkh2 (Fkh1p-dependent) &#226;&#338;&#172;ndd1 fkh2&#226;&#338;&#172;C                    accumulation Clb1,2 (Yeong et al. 2002). We have <br /> (Fkh2p&#226;&#338;&#172;C-dependent) strains. Under circum-                     observed inverse relationship Clb2 ki- <br /> stances, intact FHA domain required (D. Rey-             nase activity conditional mutants Ndd1p tran- <br /> nolds S. Dalton, unpubl.) leading invoke role            scription (D. Reynolds S. Dalton, unpubl.). This may <br /> for uncharacterized Ndd1p-like coactivator. Be-            involve mechanism Clb2 acts through <br /> cause FHA domains interchangeable, propose               Clb3,4 suppress NDD1 transcription. This issue <br /> this coactivator activate Fkh1p                    awaits characterization. <br /> Fkh2p&#226;&#338;&#172;C. This explain subtle differences the <br /> periodicity magnitude activation seen in <br />                                                                      FHA-dependent recruitment Ndd1p CLB <br /> &#226;&#338;&#172;fkh1 &#226;&#338;&#172;fkh2 strains. Our model indicate that <br />                                                                      cluster promoters <br /> although Fkh2p activated exclusively Ndd1p, <br /> Fkh1p-dependent transcription utilizes separate coac-              Our work established Ndd1p recruited pro- <br />                                                                      moters FHA domain Fkh2p that <br />                                                                      Ndd1p assembles complexes Fkh2p cell ly- <br />                                                                      sates. Whether direct interaction requires an <br />                                                                      intermediate bridging protein established. <br />                                                                      Attempts answer question ongoing. Recruit- <br />                                                                      ment Ndd1p Fkh1p (in &#226;&#338;&#172;fkh2 strains; Koranda et al. <br />                                                                      2000) ability Fkh1p FHA domain <br />                                                                      function Fkh2p chimera (this report) argues that <br />                                                                      Ndd1p recruited promoters Fkh1p vivo. <br />                                                                      As described above, believe redundant coacti- <br />                                                                      vator act Fkh1p making Ndd1p dispensable for <br />                                                                      function. This explain CLB cluster <br />                                                                      genes, CDC20, regulated Ndd1p-inde- <br />                                                                      pendent mechanism (Loy et al. 1999). Perhaps CDC20 is <br />                                                                      controlled mechanism involving Fkh1p a <br />                                                                      second coactivator, independent Ndd1p. <br />                                                                         The mechanism Ndd1p recruitment clearly in- <br /> Figure 9. A model explain mechanism CLB               volves T319, probably phosphorylation-medi- <br /> cluster genes activated Ndd1p G2&#226;&#8364;&#8220;M, based       ated mechanism. Our work showed, however, that <br /> finding described report. The model reconciles           Ndd1p recruitment CLB2 SWI5 promoters could <br /> Ndd1p specifically works Fkh2p Cdc28-Clb <br />                                                                      detected, albeit significantly reduced level, in <br /> kinase activity works positive feedback loop (Amon <br /> et al. 1993) activate CLB2 transcription, targeting Ndd1p <br />                                                                      T319A mutation. It possible T319 phosphory- <br /> on T319. The existence additional coactivator pro-     lation absolutely essential recruitment sig- <br /> posed. (Left) The control CLB cluster genes wild-type cells.   nificantly enhances efficiency. It interesting <br /> (Right) Redundant control pathways operate con-       determine effects making mutant T319 <br /> ditions primary pathway disrupted.                      substituted acidic residue mimic constitutive <br />  <br />  <br /> 1798       GENES &amp; DEVELOPMENT <br />                                                                                       Mechanism mitotic transcriptional control <br />  <br />  <br />  <br /> phosphorylation. This experiment included           role Cdk regulation the <br /> part study Ndd1p itself cell-cycle regu-    C terminus Fkh2p, critical residue Ndd1p (T319) <br /> lated degraded completion mitosis (Loy et     required function recruitment Fkh2p was <br /> al. 1999). Hence, event Ndd1pT319E/G           shown phosphorylated Cdc28-Clb-dependent <br /> produced, unlikely pronounced effect. In-      mechanism. The ability phosphorylate residue in <br /> stead, expression stable version activated         vitro purified Cdk complexes supports model that <br /> Ndd1p desirable, pre-           Cdk-Clb kinase acts directly Ndd1p. It possible that <br /> dicted deregulate Fkh2p-dependent transcription, per-       components transcriptional machinery, in- <br /> haps making constitutive. Hence, Ndd1p activity          cluding Mcm1p Fkh2p, targeted Cdks through <br /> the cell cycle regulated multiple mecha-            nonconsensus sites cell-cycle regulated mi- <br /> nisms&#226;&#8364;&#8221;transcriptional, protein stability, recruit-         totic kinases acting collaboration Cdk&#226;&#8364;&#8482;s. <br /> ment Fkh2p-containing complexes.                             Although Fkh2p-dependent mechanisms control <br />    Although C terminus Fkh2p appears           G2&#226;&#8364;&#8220;M transcription, determined FKH1-de- <br /> essential target Ndd1p activity, region re-     pendent CLB cluster control (i.e., FKH1 &#226;&#338;&#172;fkh2) cell- <br /> quired Ndd1p recruitment. Instead, intact FHA           cycle regulated dependent Clb kinase activity (D. <br /> domain capable binding pThr epitopes required. Be-       Reynolds S. Dalton, unpubl.). Hence, mitotic Cdk <br /> cause Ndd1p recruitment probably pThr 319-depen-            activity role Fkh1p Fkh2p-dependent <br /> dent, tempted speculate Ndd1p           transcriptional control. <br /> the pThr ligand Fkh2p FHA domain. Although             An intriguing finding work Ndd1p <br /> have direct physical evidence support this,      T319 phosphorylation influenced cdc28-1n <br /> lines evidence consistent possibility.        mutant, vitro retains kinase activity (Surana et <br /> First, recruitment Ndd1p Fkh2p pThr-dependent.        al. 1991). Our results, however, clearly ac- <br /> Second, mutations block FHA&#226;&#8364;&#8220;pThr interactions             tivity vivo compromised restrictive tempera- <br /> also severely reduce recruitment phosphorylated             ture. The possibility indirect effect on <br /> Ndd1p. Third, failure recruit Ndd1p promoters         Ndd1p unlikely similar results obtained <br /> Fkh2p results transcriptional defect reminiscent       clb2 ts mutant. The issue correlating vitro <br /> an inactivated forkhead pathway, finally, deletion      vivo kinase activity difficult one, particularly <br /> NDD1 similar <span id='am-160' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-161' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-169' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-173' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-176' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-177' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-179' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-181' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-185' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-186' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-188' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-189' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-190' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-191' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-194' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-196' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-198' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-204' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-207' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-210' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-211' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-216' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-217' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-221' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-223' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-227' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-231' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span>lethal phenotype</span> cells carrying       dealing conditional mutants Cdks. It has <br /> R87A mutation FKH2 locus (D. Reynolds S.            proposed preformed Cdc28pts-cyclin <br /> Dalton, unpubl.). The question direct interactions be-      complexes readily inactivated shift the <br /> tween Fkh2p Ndd1p requires investigation.          restrictive temperature, leaving possibility alle- <br />    The T319A mutant used studies does             les cdc28-1n defective aspect of <br /> completely block ability Ndd1p recruited       kinase activity vivo, display robust <br /> promoters. This reflected impaired, extin-       activity vitro restrictive temperature (Amon et al. <br /> guished transcriptional activity, pronounced mor-        1997). For example, kinase localization, substrate access, <br /> phology similar &#226;&#338;&#172;fkh1 &#226;&#338;&#172;fkh2 deletion strains           assembly Cdks complexes required in <br /> (Hollenhorst et al. 2000; Kumar et al. 2000; Pic et al.        vivo activity, account differences in <br /> 2000; Zhu et al. 2000). When expressed            vivo vitro activity. Subtle changes levels of <br /> promoter, chromosomal locus, Ndd1pT319A             kinase activity vivo pronounced bio- <br /> lethal &#226;&#338;&#172;ndd1 background. In contrast, ex-            logical effects seen using conventional in <br /> pressed high-copy number plasmid control          vitro kinase assays. These factors contribute to <br /> of ADH1 promoter, aberrant morphology            normal phosphorylation substrates in- <br /> be partially suppressed. Hence, believe            ability phosphorylate others. These points emphasize <br /> T319A mutant minimal activity expressed            need evaluate phosphorylation status sub- <br /> elevated levels, acts partial loss function   strates vivo, performed report. <br /> mutant, physiological levels.                          In light recent observations forkhead transcrip- <br />                                                                tion factors involved G2/M transcriptional control <br />                                                                mammalian cells, interesting determine if <br /> A role Cdc28-Clb kinase activity CLB cluster <br />                                                                pathways identified report conserved <br /> gene activation <br />                                                                (Alvarez et al. 2001). <br /> Amon et al. (1993) proposed Clb-dependent kinase <br /> activity acted positive feedback loop activate and <br /> maintain CLB2 (CLB cluster) transcription. We sought        Materials methods <br /> identify mechanism Cdc28-Clb kinases ac- <br /> tivated G2&#226;&#8364;&#8220;M transcription identifying targets      Strains, media, reagents, yeast genetic protocols <br /> kinase transcriptional complexes         All yeast strains derivatives W303 (MATa MAT&#226;?&#163; ho <br /> that formed CLB cluster promoters. As          ade2-1 trp1-1 can1-100 leu2-3, 112 his3-11, 15 ura3-1 ssd1) ex- <br /> study, showed CLB2UAS subject Clb            cept indicated listed Table 1. Yeast <br /> kinase regulation, implicating Mcm1p, forkhead tran-           strains grown YEP medium appropriate selective <br /> scription factors Ndd1p potential targets. Al-          medium described previously (Dalton Treisman 1992; <br />  <br />  <br />                                                                                            GENES &amp; DEVELOPMENT              1799 <br />  Reynolds et al. <br />  <br />  <br /> Table 1.   Yeast strains used study <br />  <br /> Strain                                              Genotype                                                  Source <br />  <br /> W303 1a              MATa ho ade2-1 trp1-1 can1-100 leu2-3 his3-11 ura3-52 ssd1                         Rodney Rothstein <br /> US262                MATa ndd1::LEU2 pGAL&#226;&#8364;&#8220;NDD1                                                          Loy et al. 1999 <br /> MK146                MATa ndd1::LEU2 pGAL&#226;&#8364;&#8220;NDD1 &#226;&#338;&#172;fkh1::TRP1 fkh2::HIS3                                   Koranda et al. 2000 <br /> MK465                MATa ndd1::LEU2 pGAL&#226;&#8364;&#8220;NDD1 FKH1 fkh2::HIS3                                          Koranda et al. 2000 <br /> S272                 MATa cdc28-1n                                                                      Surana et al. 1991 <br /> S287                 MATa bar1 ura3::CLB2UAS&#226;&#8364;&#8220;ubiYLacZ                                                   Maher et al. 1995 <br /> S315                 MATa, clb1 &#226;&#338;&#172; clb2-VI clb3::TRP1 clb4::HIS3 ura3::CLB2UAS&#226;&#8364;&#8220;ubiYLacZ                  Amon et al. 1993 <br /> S466                 MATa bar1 fkh1::LEU2 ura3::CLB2UAS&#226;&#8364;&#8220;ubiYLacZ                                        Kumar et al. 2000 <br /> S508                 MATa bar1 fkh2::LEU2 ura3::CLB2UAS&#226;&#8364;&#8220;ubiYLacZ                                        This study <br /> S599                 US262 pADH.NDD1                                                                    This study <br /> S600                 S599 fkh2::fkh26myc&#226;&#8364;&#8220;TRP1                                                           This study <br /> S601                 S599 fkh2::fkh2&#226;&#338;&#172;C.6myc&#226;&#8364;&#8220;TRP1                                                        This study <br /> S602                 S599 fkh2::fkh2&#226;&#338;&#172;6Cdk.6myc&#226;&#8364;&#8220;TRP1                                                     This study <br /> S610                 MATa fkh1::TRP1 fkh2::HIS3                                                         This study <br /> S618                 S466 fkh2::fkh2&#226;&#338;&#172;C&#226;&#8364;&#8220;TRP1                                                             This study <br /> S619                 S618 ndd1::HIS3                                                                    This study <br />  <br />  <br />  <br />  <br /> Maher et al. 1995; Kumar et al. 2000). Single-copy integrations    growth morphological defects observed tagged <br /> were confirmed Southern blot PCR analysis. Gene disrup-      strain confirming functionality. <br /> tions, yeast transformations, yeast techniques        A GALDBD&#226;&#8364;&#8220;FKH2 fusion gene (G.FKH2HA) constructed <br /> by standard methods (Guthrie Fink 1991). Liquid culture        inserting 867-bp NcoI&#226;&#8364;&#8220;BamHI cut PCR fragment into <br /> and qualitative plate-based assays used determine &#226;?&#164;-galacto-    NcoI&#226;&#8364;&#8220;BamHI cut pAS2 (URA3, 2 &#194;&#181;; Clontech): 5&#226;&#172;&#732;-CC.ATG . <br /> sidase activity described (Dalton Treisman 1992;       GCC. . .AAT.ACC (FKH2 codon 291).TAG. GGA.TCC-3&#226;&#172;&#732;. <br /> Maher et al. 1995).                                                G.FKH2R87A.HA identical G.FKH2HA codon 87 <br />                                                                    changed arginine alanine. GAL1UAS&#226;&#8364;&#8220;LacZ, <br />                                                                    CYC1UAS&#226;&#8364;&#8220;LacZ, RP39UAS&#226;&#8364;&#8220;LacZ &#226;&#338;&#172;UAS&#226;&#8364;&#8220;LacZ reporter plas- <br /> Plasmid constructions generation yeast strains              mids (URA3, 2 &#194;&#181;) described previously (Dalton and <br />                                                                    Treisman 1992; Maher et al. 1995). <br /> Except specified, constructs described pre- <br />                                                                      Fkh1p&#226;&#8364;&#8220;Fkh2p fusion proteins follows: 1/2p-1, <br /> viously (Maher et al. 1995; Kumar et al. 2000). Strains express- <br />                                                                    Fkh1p1&#226;&#8364;&#8220;484&#226;&#8364;&#8220;Fkh2p574&#226;&#8364;&#8220;862; 1/2p-2, Fkh1p1&#226;&#8364;&#8220;303&#226;&#8364;&#8220;Fkh2p336&#226;&#8364;&#8220;862; 1/2p- <br /> ing 6myc epitope-tagged Fkh2p, Fkh2p&#226;&#338;&#172;C, Fkh2p&#226;&#338;&#172;6Cdk were <br />                                                                    3, Fkh1p1&#226;&#8364;&#8220;303&#226;&#8364;&#8220;Fkh2p347&#226;&#8364;&#8220;444&#226;&#8364;&#8220; Fkh1p402&#226;&#8364;&#8220;484; 1/2p-4, Fkh1p1&#226;&#8364;&#8220;76&#226;&#8364;&#8220; <br /> generated integration tagged open reading frame-contain- <br />                                                                    Fkh2p83&#226;&#8364;&#8220;152&#226;&#8364;&#8220;Fkh1p142&#226;&#8364;&#8220;484. Hybrid genes inserted a <br /> ing fragments FKH2 locus (Kumar et al. 2000). The FKH2 <br />                                                                    YCplac33-based expression vector control GAL1 <br /> open reading frame derivatives epitope-tagged by <br />                                                                    promoter (CEN ARS1 URA3). Constructs evaluated in <br /> inserting 6myc tag NotI site immediately the <br />                                                                    &#226;&#338;&#172;fkh1 &#226;&#338;&#172;fkh2 strain confirm functional. <br /> STOP codon YIplac204 (Gietz Sugino 1988). Fkh2p&#226;&#338;&#172;C is <br /> Fkh2p amino acids 1&#226;&#8364;&#8220;584.6myc Fkh2p&#226;&#338;&#172;6Cdk full-<span id='am-2' about='xsp:length' typeof='owl:Thing'>length</span> <br />                                                                    Northern analysis, cell synchronization, <br /> Fkh2p carries alanine substitutions serine threonine <br />                                                                    immunoprecipitations, kinase assays, ChIP assays <br /> residues positions 589, 683, 697, 759, 771, 833. These <br /> were integrated FKH2 locus strain S508 (see Table 1).    Northern blot analysis, probe preparation, &#226;?&#163;-factor synchro- <br />    To create DNA construct disrupt NDD1 gene,         nizations described previously (Dalton Whit- <br /> entire ORF NDD1 amplified PCR, subcloned            bread 1995; Maher et al. 1995; Kumar et al. 2000). Whole-cell <br /> pBS.KS+ (pBS.NDD1) 1.7-kb HIS3 fragment           lysates prepared described previously bead beat <br /> inserted EcoRV MunI sites (blunt). This construct      method (Maher et al. 1995; Kumar et al. 2000). <br /> was digested EcoRI cotransformed recipient              All steps prior including immunoprecipitations were <br /> strains pADH.NDD1, plasmid expressing length           performed ice 4&#194;&#176;C. Cells grown midlog phase, <br /> Ndd1p ADH1 promoter pVT100-U (Vernet et al.            collected centrifugation, resuspended equal volume <br /> 1987; 2&#194;&#181;, URA3). URA+ transformants replica plated       lysis buffer (50 mM Hepes pH 7.9, 250 mM NaCl, 0.5 mM <br /> onto histidine-selective plates gene disruption confirmed   EDTA, 10% glycerol, 0.1% NP40, 1 mM DTT, 50 &#194;&#181;M chy- <br /> PCR analysis. Curing ndd1&#226;&#172;&#8249;HIS3 strains pADH.NDD1             mostatin, 25 &#194;&#181;M leupeptin, 0.2 &#194;&#181;M aprotinin, 0.5 mM PMSF, 50 <br /> five fluoroorotic acid (5-FOA) plates did rise     &#194;&#181;M TLCK, 100 &#194;&#181;M TPCK, 0.4 mM NaF, 0.4 mM NaVO4) to <br /> viable cells FKH2 disrupted. Triple HA-       equal volume chilled, acid-washed glass beads was <br /> tagged mutant wild-type versions Ndd1p (Ndd1p3HA)       added. Cells lysed bead-beater previously described <br /> expressed ADH1-promoter YCplac22 (pT.NDD13HA;           (Maher et al. 1995; Kumar et al. 2000) lysate clarified by <br /> CEN, ARS1, TRP1) or, derivative pADH.NDD1           centrifugation 15,000 &#195;&#8212; g 10 min. Immunoprecipitations <br /> had triple HA tag inserted immediately STOP           performed described (Harlow Lane 1988). Treat- <br /> codon (pADH.NDD13HA). The construct used recombina-            ment immune complexes &#226;?&#173;-phosphatase (NEB) pu- <br /> tion generate 6myc-tagged NDD1, locus, cre-      rified cdc2&#226;&#8364;&#8220;cyclin B complexes (NEB) described previ- <br /> ated inserting 6myc tag NotI site engineered imme-     ously (Hendrickson et al. 1996). Chromatin immunoprecipita- <br /> diately STOP codon pBS.NDD1. The construct           tion assays performed essentially described (Tanaka et <br /> was linearized cotransformed pADH.NDD1. No                al. 1997; Kumar et al. 2000). <br />  <br />  <br /> 1800       GENES &amp; DEVELOPMENT <br />                                                                                               Mechanism mitotic transcriptional control <br />  <br />  <br /> Antibodies                                                               cyclins repress G1 cyclins. Cell 74: 993&#226;&#8364;&#8220;1007. <br />                                                                      Breeden, L.L. 2000. Cyclin transcription. Timing everything. <br /> Monoclonal antibodies raised glyceraldehyde phosphate <br />                                                                          Curr. Biol. 10: R586&#226;&#8364;&#8220;R588. <br /> dehydrogenase (Gapdh) provided Trevor Lithgow (Uni- <br />                                                                      Dalton, S. Treisman, R. 1992. Characterization SAP-1, a <br /> versity Melbourne). Polyclonal phospho-Ndd1pT319 <br />                                                                          protein recruited serum response factor c-fos serum <br /> (pNdd1T319) antibodies generated using phosphorylated <br />                                                                          response element. Cell 68: 597&#226;&#8364;&#8220;612. <br /> peptide (CILQRpTPLRS-NH2) immunize rabbits. The pep- <br />                                                                      Dalton, S., Whitbread, L. 1995. Cell cycle-regulated nuclear <br /> tide synthesized free cysteine N terminus for <br />                                                                          import export Cdc47, protein essential initiation <br /> coupling SulphoLink Coupling Gel (Pierce) manu- <br />                                                                          DNA replication budding yeast. Proc. Natl. Acad. Sci. <br /> facturer&#226;&#8364;&#8482;s instructions. Phosphospecific antibodies puri- <br />                                                                          92: 2514&#226;&#8364;&#8220;2518. <br /> fied depleting antibodies recognized unphos- <br />                                                                      Durocher, D. Jackson, S.P. 2002. The FHA domain. FEBS <br /> phorylated peptide, followed purification column to <br />                                                                          Lett. 513: 58&#226;&#8364;&#8220;66. <br /> which phosphorylated peptide coupled. SulfoLink Cou- <br />                                                                      Durocher, D., Taylor, I.A., Sarbassova, D., Haire, L.F., Westcott, <br /> pling gel (5 mL 50% slurry) washed times cou- <br />                                                                          S.L., Jackson, S.P., Smerdon, S.J., Yaffe, M.B. 2000. The <br /> pling buffer (50 mM Tris-HCl pH 8.5, 5 mM EDTA) and <br />                                                                          molecular basis FHA domain:phosphopeptide binding <br /> resuspended final volume 8 mL. Five milligrams pep- <br />                                                                          specificity implications phospho-dependent signal- <br /> tide added gel, mixed gently 60 min 4&#194;&#176;C and <br />                                                                          ling mechanisms. Mol. Cell 6: 1169&#226;&#8364;&#8220;1182. <br /> uncoupled peptide removed additional washes cou- <br />                                                                      Futcher, B. 2002. Transcriptional regulatory networks the <br /> pling buffer finally resuspended 8 mL coupling <br />                                                                          yeast cell cycle. Curr. Opin. Cell Biol. 14: 676&#226;&#8364;&#8220;683. <br /> buffer. Uncoupled site beads blocked addi- <br />                                                                      Guthrie, C. Fink, G. 1991. Guide yeast genetics and <br /> tion 2-mercaptoethanol 50 mM 60 min 4&#194;&#176;C. The gel <br />                                                                          molecular biology. Meth. Enzymol. Academic press, Vol. <br /> was washed times 8 mL coupling buffer, times in <br />                                                                          194. <br /> 1 M NaCl times PBS. Up 25 mL crude sera <br />                                                                      Gietz, R.D. Sugino, A. 1988. New yeast&#226;&#8364;&#8221;Escherichia coli <br /> was mixed unphosphorylated peptide column 2 h at <br />                                                                          shuttle vectors constructed vitro mutagenized yeast <br /> 4&#194;&#176;C. This poured 10-mL EconoColumn (Bio- <br />                                                                          genes lacking six-<span id='am-238' about='xsp:base' typeof='owl:Thing'>base</span> pair restriction sites. Gene 30: 527&#226;&#8364;&#8220; <br /> Rad) gel washed 10 column volumes PBS. If <br />                                                                          534. <br /> necessary, flow-through reapplied nonphospho <br />                                                                      Hammet, A., Pike, B.L., Mitchelhill, K.I., Teh, T., Kobe, B., <br /> column deplete antibodies recognizing nonphospho- <br />                                                                          House, C.M., Kemp, B.E., Heierhorst, J. 2000. FHA do- <br /> peptide (monitored ELISA assay). Antibodies flow- <br />                                                                          main boundaries dun1p rad53p cell cycle check- <br /> through applied second column phos- <br />                                                                          point kinases. FEBS Lett. 471: 141&#226;&#8364;&#8220;146. <br /> phorylated peptide coupled. After loading flow- <br />                                                                      Harlow, E. Lane, D. 1988. Antibodies: A laboratory <br /> through column, gel washed 10 column <br />                                                                          manual. Cold Spring Harbor Laboratory Press, New York. <br /> volumes PBS bound antibodies eluted 7 mL 0.2 M <br />                                                                      Hendrickson, M., Madine, M., Dalton, S., Gautier, J. 1996. <br /> glycine pH 2.5. Each 500 &#194;&#181;L fraction collected 100 <br />                                                                          Phosphorylation MCM4 cdc2 protein kinase inhibits <br /> &#194;&#181;L 2 M Tris-HCl pH 7.5. Enrichment phosphospecific <br />                                                                          activity minichromosome maintenance complex. <br /> antibodies assayed ELISA phospho nonphos- <br />                                                                          Proc. Natl. Acad. Sci. 93: 12223&#226;&#8364;&#8220;12228. <br /> phorylated peptide (Harlow Lane 1988). <br />                                                                      Hofmann, K. Bucher, P. 1995. The FHA domain: A putative <br />                                                                          nuclear signalling domain protein kinases tran- <br />                                                                          scription factors. Trends Biochem. Sci. 20: 347&#226;&#8364;&#8220;349. <br /> Acknowledgments                                                      Hollenhorst, P.C., Bose, M.E., Mielke, M.R., Muller, U., a <br /> </body></html>